Age at menopause of HIV-infected women: a review.
The advent of highly active antiretroviral therapy has promoted a reduction in mortality due to HIV. Thus more women are living longer after receiving a diagnosis of HIV infection. With an increase in survival, topics related to the menopausal transition in HIV-infected women have emerged, such as age at menopause, bone mineral density and menopause-related symptoms. To this end, several studies have investigated age at menopause (AM) in HIV-infected women. The present paper reviews these studies and discusses the possible clinical implications of determining AM for HIV-positive women.
Conde
Délio Marques
DM
Department of Gynecology and Obstetrics, Universidade Federal de Goiás, Goiânia, Goíás, Brazil. condedelio@uol.com.br
Pinto-Neto
Aarão Mendes
AM
Costa-Paiva
Lúcia
L
D017668:Age of Onset; D023241:Antiretroviral Therapy, Highly Active; D015992:Body Mass Index; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D008593:Menopause / Q000276:immunology / Q000502:physiology*; D008594:Menopause, Premature / Q000502:physiology